Company has posted a loss of Rs 2.94 cr in 31 Dec, 2023 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
Bafna Pharmaceuticals Share Price
Bafna Pharma share price insights
Company witnessed QoQ revenue decline of 27.95%, which is lowest in the last 3 years. (Source: Standalone Financials)
Company has spent 1.77% of its operating revenues towards interest expenses and 13.75% towards employee cost in the year ending 31 Mar, 2023. (Source: Standalone Financials)
Bafna Pharmaceuticals Ltd. share price moved down by -4.97% from its previous close of Rs 104.80. Bafna Pharmaceuticals Ltd. stock last traded price is 99.60
Share Price Value Today/Current/Last 99.60 Previous Day 104.80
Key Metrics
PE Ratio (x) | 18.17 | ||||||||||
EPS - TTM (₹) | 4.76 | ||||||||||
MCap (₹ Cr.) | 248.39 | ||||||||||
Sectoral MCap Rank | 86 | ||||||||||
PB Ratio (x) | 4.00 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.15 | ||||||||||
VWAP (₹) | 99.60 | ||||||||||
52W H/L (₹) |
Bafna Pharma Share Price Returns
1 Day | -4.97% |
1 Week | 0.0% |
1 Month | 14.75% |
3 Months | 10.67% |
1 Year | 10.79% |
3 Years | -27.19% |
5 Years | 1145.0% |
Bafna Pharma News & Analysis
Stock market update: Stocks that hit 52-week highs on NSE
NewsStock market update: Nifty Bank index advances 1.45% in an upbeat market
NewsAhead of Market: 12 things that will decide stock action on Monday
NewsAnnouncement Regarding Inauguration Of New Quality Control Laboratory Of Company
Announcements
Bafna Pharma Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Peer Comparison
Bafna Pharma Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Bafna Pharma Board Meeting/AGM
Bafna Pharma Dividends
- Others
Meeting Date Announced on Purpose Details Feb 12, 2024 Feb 02, 2024 Board Meeting Quarterly Results Nov 09, 2023 Oct 30, 2023 Board Meeting Quarterly Results Sep 22, 2023 Aug 11, 2023 AGM - Aug 11, 2023 Aug 03, 2023 Board Meeting Quarterly Results May 27, 2023 May 23, 2023 Board Meeting Audited Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 6% 0.6 Sep 19, 2013 May 21, 2013 No other corporate actions details are available.
About Bafna Pharma
Bafna Pharmaceuticals Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 235.97 Crore) operating in Pharmaceuticals sector. Bafna Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023. Show More
Executives
Auditors
- SH
S Hemalatha
Chairperson & Executive DirectorBMBafna Mahaveer Chand
Chief Executive OfficerACAkila C Raju
Non Exe.Non Ind.DirectorBKB Kamlesh Kumar
Ind. Non-Executive DirectorShow More - Brahmayya & Co.R Satyanarayanan & Co.
Industry
Key Indices Listed on
-
Address
Bafna Towers,New�No.�68,�Old�No. 299,�� �Thambu Chetty Street,Chennai (Madras), Tamil Nadu - 600001
More Details
FAQs about Bafna Pharma share
- 1. What's Bafna Pharma share price today and what are Bafna Pharma share returns ?As on 13 May, 2024, 03:40 PM IST Bafna Pharma share price was down by 4.97% basis the previous closing price of Rs 104.8. Bafna Pharma share price was Rs 99.60. Return Performance of Bafna Pharma Shares:
- 1 Week: Bafna Pharma share price moved remain unchanged by 0.00%
- 1 Month: Bafna Pharma share price moved up by 14.75%
- 3 Month: Bafna Pharma share price moved up by 10.67%
- 6 Month: Bafna Pharma share price moved up by 14.35%
- 2. Who are the peers for Bafna Pharma in Pharmaceuticals sector?Top 10 Peers for Bafna Pharma are Brooks Laboratories Ltd., SMS Lifesciences India Ltd., Alpa Laboratories Ltd., Vaishali Pharma Ltd., Bal Pharma Ltd., Mangalam Drugs and Organics Ltd., Par Drugs & Chemicals Ltd., Krebs Biochemicals & Industries Ltd., Aarey Drugs & Pharmaceuticals Ltd. and Medico Remedies Ltd.
- 3. Who is the CEO of Bafna Pharma?Bafna Mahaveer Chand is the Chief Executive Officer of Bafna Pharma
- 4. What is the market cap of Bafna Pharma?Within the Pharmaceuticals sector, Bafna Pharma stock has a market cap rank of 86. Bafna Pharma has a market cap of Rs 248.39 Cr.
- 5. What is Bafna Pharma's 52 week high / low?Bafna Pharma share price saw a 52 week high of Rs 124.45 and 52 week low of Rs 75.90.
- 6. Who are the key owners of Bafna Pharma stock?Following are the key changes to Bafna Pharma shareholding:
- Promoter holding have gone down from 90.0 (30 Jun 2023) to 88.3 (31 Mar 2024)
- Other investor holding has gone up from 10.0 (30 Jun 2023) to 11.7 (31 Mar 2024)
- 7. What are the key metrics to analyse Bafna Pharma Share Price?Bafna Pharma share can be quickly analyzed on following metrics:
- Stock's PE is 18.17
- Price to Book Ratio of 4.00
Trending in Markets
Bafna Pharma Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.